Benzinga's Top Upgrades (CAVM, EMR, ARMH, BMY)

Cavium Networks Inc CAVM was upgraded by Auriga from "hold" to "buy." CAVM's shares closed at $42.93 yesterday. Cavium Networks' trailing-twelve-month ROE is 18.99%. Deutsche Bank upgraded Emerson Electric Company EMR from “hold” to “buy.” EMR's shares closed at $57.41 yesterday. EMR's PEG ratio is 1.15. BofA/Merrill upgraded ARM Holdings plc ARMH from “neutral” to “buy.” ARMH's shares closed at $27.53 yesterday. ARMH's trailing-twelve-month operating margin is 26.21%. Analysts at Jefferies upgraded Bristol Myers Squibb Co BMY from “underperform” to “hold.” BMY's shares closed at $26.47 yesterday. Bristol Myers Squibb's trailing-twelve-month revenue is $19.48 billion. More Analyst Ratings here